Try our Advanced Search for more refined results
OVERTON et al v. SANOFI-AVENTIS U.S., LLC
September 04, 2015
Sanofi-Aventis US LLC has agreed to pay $2.4 million to employees who alleged the pharmaceutical giant shorted them commission payments from sales of the cancer drug Zaltrap, according to a preliminary settlement filed Friday in federal court in New Jersey
September 19, 2013
Two former Sanofi-Aventis US LLC sales employees hit the pharmaceutical giant with a putative class action Tuesday, claiming the company backtracked on commission agreements stemming from sales of the cancer drug Zaltrap.